SEC Form 4 · accession 0001562180-16-002785
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin S Gould
Officer — SVP Clinical Controls
Period of report
Jul 9, 2016
Accepted (ET)
Jul 12, 2016 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 9, 2016 | F | 309 | $115.17 | D | 2,191 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F3 | $97.23 | holding | — | — | — | — | Jul 9, 2022 | Common Stock | 50,000 | 50,000 | D |
| Stock Options (Right to buy)F4 | $97.23 | holding | — | — | — | — | Jul 9, 2022 | Common Stock | 15,000 | 15,000 | D |
| Stock Options (Right to buy)F5 | $88.23 | holding | — | — | — | — | Jan 4, 2023 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F11. The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock unit gran by directing the Company to withhold shares otherwise issuable pursuant to the previously reported grant.
- F22. Includes 833 shares of restricted stock units that vest on 7/9/17 and 834 shares of restricted stock units that vest on 7/9/18.
- F34. 50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/2018.
- F43. Vests as to 3,750 shares on each of 07/09/16, 07/09/17, 07/09/18 and 07/09/19.
- F55. Vests as to 2,500 shares on each of 01/04/2017, 01/04/2018, 01/04/2019 and 01/04/2020.